Actual Medicinal Product (AMP) Plenadren 5mg modified-release tablets (Abacus Medicine Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Store in airtight containers.
- Provenance
-
This compatibility recommendation is derived from Plenadren 5mg modified-release tablets (Takeda UK Ltd).
- Generic
- Hydrocortisone
- Formulation
- Hydrocortisone 5mg modified-release tablets
-
Hydrocortisone
-
Hydrocortisone 5mg modified-release tablets
-
Plenadren 5mg modified-release tablets (Abacus Medicine Ltd)
-
-
Hydrocortisone 2mg capsules
Hydrocortisone 2.5mg muco-adhesive buccal tablets sugar free